Close

Sign in
Sign up

Menu

Data Search
Content
Startup Concierge
Newsletters
Get intel

Home
News
NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

NRG Therapeutics closed a £50 million Series B funding round w/ British Business Bank, SV Health, M Ventures, Novartis, Criteria Bio Ventures, Omega Funds

Biotech Health services Pharma

Spain

Switzerland

United Kingdom

Netherlands

United States

Australia

Investments

01 September 2025

Share:

Interested in more dealflow and deeper data sets from Europe? Please consider joining Nordic 9!

NRG Therapeutics (company)

United Kingdom

Biotech Health services Pharma

Total investments received (USD): 85.97M

Round value (USD): 67.25M

Round investors: SV Health Investors Merck Ventures Novartis Venture Fund Caixa Capital Risc Brandon Capital Partners Omega Funds British Business Bank

Company: NRG Therapeutics

Industry: Biotech Health services Pharma

Related deals

Charm Therapeutics raised $80M Series B round co-led by New Enterprise Associates and SR One, w/ OrbiMed, F-Prime Capital, Khosla Ventures, and NVIDIA

AI (big data) Biotech Health services Software Services

United Kingdom

United States

Investments 02 August 2025

Juvenescence raised $76m in a first close of its Series B1 round led by M42.

Biotech Health services Manufacturing Pharma

United Kingdom

United States

Australia

United Arab Emirates

Investments 10 May 2025

Sidebar

Verticals

Financial Services
Food Industry
Education
E-commerce
Health services
Marketplace

Benelux

Belgium
Netherlands

DACH

Austria
Germany
Switzerland

Nordics and Baltics

Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden

Western Europe

France
Ireland
Italy
Portugal
Spain
United Kingdom

About
Contact
Terms of service
Privacy policy

© All rights reserved Nordic 9 2016-2025. Made with in Stockholm

Top